Certolizumab Pegol Efficacy in Patients With Non-Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C-Reactive Protein Status: An Analysis From the C-axSpAnd Study.
Philip C RobinsonWalter P MaksymowychLianne S GenslerStephen HallMartin RudwaleitBengt HoepkenLars BauerThomas KumkeMindy KimNatasha de PeyrecaveAtul A DeodharPublished in: ACR open rheumatology (2022)
Our findings indicate that CZP treatment benefits patients with nr-axSpA across MRI+/CRP+, MRI-/CRP+, and MRI+/CRP- subgroups.